SlideShare ist ein Scribd-Unternehmen logo
1 von 38
Epstein-Barr Virus
Infectious mononucleosis
• Caused by Epstein-Barr virus (EBV).
• Characterized by:
fatigue, malaise, fever, sore throat, and
generalized lymphadenopathy.
• Was called glandular fever:
Because it has mononuclear lymphocytosis with
atypical- lymphocytes.
Other infections may cause infectious
mononucleosis-like illnesses
ETIOLOGY
• EBV, a member of the γ-herpesviruses, causes >90% of
cases of infectious mononucleosis.
• Two distinct types of EBV:
- type 1 (type A): more prevalent worldwide
- type 2 (type B): more common in Africa
• Both types lead to persistent, lifelong, latent infection.
• Dual infections with both types have been documented
among immunocompromised persons.
Infectious mononucleosis-like illnesses
5–10% of are caused by:
- CMV
-Toxoplasma gondii
- adenovirus
- viral hepatitis
- HIV
- rubella virus.
• Causes of majority of mononucleosis-like illnesses still
unknown.
EPIDEMIOLOGY
• EBV infects >95% of the world's population.
• Transmitted by:
1. sexual intercourse
2. through oral secretions.
3. In children by exchange of saliva
• Not transmitted by:
- Nonintimate contact
- fomites.
• EBV is shed in oral secretions consistently
for >6 mo after acute infection and then
intermittently for life.
• 20–30% excrete virus at any particular time.
• 60–90% in infected immunosuppressed
patients.
• Immunosuppression help reactivation of
latent EBV
• Also found in male and female genital
secretions.
• Infection with EBV occurs during infancy and
early childhood.
• 1ry infection in children usually inapparent.
• in >50% adolescents and adults:
classic triad:
- fatigue
- pharyngitis
- generalized lymphadenopathy.
INCIDENCE:
• Estimated: up to 70/100,000 persons/yr.
• in young adults:1/1,000 persons/yr.
• Almost all adults in USA are seropositive.
PATHOGENESIS
• Infection of the oral epithelial cells cause pharyngitis
• viral replication and cell lysis.
• spreads to near structures as the salivary glands
• viremia and infection of B lymphocytes and the
lymphoreticular system, including the liver and
spleen.
• Characteristic atypical lymphocytes are CD8+
T lymphocytes.
• Transient reversal of the normal 2 : 1
CD4+/CD8+(helper:suppressorT-lymphocytes)
• This causes cytokine release which causes
many of the clinical manifestations.
• Sexual transmission infects the epithelial cells of
the uterine cervix.
• EBV is consistently found intracellularly in
smooth muscle cells of leiomyosarcomas of
immunocompromised persons.
• EBV has lifelong latent infection after the primary
illness.
• The latent virus found in oropharyngeal epithelial
cells and in memory B lymphocytes.
ONCOGENESIS
• EBV was the 1st human virus to be associated
with malignancy.
• Spectrum of EBV infection:
- self-limited infectious mononucleosi
- nonmalignant proliferations
- malignancies in lymphoid and epithelial cell.
ONCOGENESIS-2
• Benign EBV-associated proliferations include:
- Oral hairy leukoplakia, primarily in adults with AIDS
- Lymphoid interstitial pneumonitis, in children with AIDS.
• Malignant EBV-associated proliferations include:
- nasopharyngeal carcinoma
- Burkitt lymphoma
- Hodgkin disease
- lymphoproliferative disorders, and
- leiomyosarcoma in immunodeficient including AIDS.
Nasopharyngeal carcinoma
• It is worldwide
• 10 times more common in southern China,
where it is the most common malignant tumor
among adult men.
• Patients present with:
- cervical lymphadenopathy
- eustachian tube blockage
- nasal obstruction with epistaxis.
Nasopharyngeal carcinoma-cont
• Patients have elevated EBV antibody titers that are both
diagnostic and prognostic.
Nasopharyngeal carcinoma-cont
• Diagnosis:
- CT and MRI
- Biopsy from lymph nodes or masses
- Surgery is important for staging and diagnosis.
Treatment:
• Radiation therapy is effective for control of the
primary tumor and regional nodal metastases.
• Chemotherapy is effective but not always curative.
Prognosis: good if the tumor is localized.
Endemic (African) Burkitt
lymphoma
• Often in the jaw
• The most common childhood cancer in equatorial East Africa
• The median age at onset is 5 yr.
• These regions are endemic for Plasmodium falciparum
malaria and have a high rate of EBV infection early in life.
• Malarial exposure acts as a B-lymphocyte mitogen
increasing the risk of Burkitt lymphoma.
• Approximately 98% of cases of endemic Burkitt lymphoma
contain the EBV genome.
1Other Malignancies-
• Infection with EBV also increase the risk for Hodgkin disease.
• EBV is find in the Reed-Sternberg cells which are pathognomonic
malignant cells of Hodgkin disease.
• Duncan syndrome: (X-linked lymphoproliferative syndrome):
is associated with severe, persistent, and fatal EBV infection .
• Many Immunodeficiency syndromes are associated with an increased
incidence of EBV-associated B-lymphocyte lymphoma include:
- X-linked lymphoproliferative syndrome,
- common-variable immunodeficiency,
- ataxia-telangiectasia,
- Wiskott-Aldrich syndrome, and
- Chédiak-Higashi syndrome.
- T-lymphocyte lymphomas (including lethal midline)
- angio-immunoblastic lymphadenopathy-like lymphoma
- thymomas and thymic carcinomas
- supraglottic laryngeal carcinomas
- lympho-epithelial tumors of the respiratory tract and GIT.
- gastric adenocarcinoma.
2Other Malignancies-
CLINICAL MANIFESTATIONS
of EBV infection
• The incubation period: 30–50 days.
• 1ry infection in infants and young children is silent.
• In older patients: insidious and vague onset.
Prodromal symptoms: last 1–2 wk.
• Malaise
• fatigue
• Fever & headache
• sore throat, nausea, abdominal pain
• myalgia.
• Splenic enlargement :may cause left upper
abdominal discomfort and tenderness
Physical examination
• generalized lymphadenopathy (90% of cases),
• splenomegaly (50% of cases),
• hepatomegaly (10% of cases).
• Lymphadenopathy :
Common in: - anterior and posterior cervical
- submandibular
less common in: axillary and inguinal.
Epitrochlear lymphadenopathy is suggestive of
infectious mononucleosis.
• elevated liver enzymes are common.
• Splenomegaly to 2–3 cm below the costal
margin is typical; massive enlargement is
uncommon.
• The sore throat is often accompanied by
moderate to severe pharyngitis with marked
tonsillar enlargement, occasionally with
exudates .
• Petechiae at junction of the hard and soft palate
• Others: rashes and edma of the eyelids .
• Maculopapular in 3–15% of patients
• Up to 80% of patients have “ampicillin rash” if treated
with ampicillin or amoxicillin.
• This vasculitic rash is immune mediated and resolves
without specific treatment.
• Gianotti-Crosti syndrome: a symmetrical rash on the
cheeks with multiple erythematous papules, which may
coalesce into plaques, and persists for 15–50 days.
DIAGNOSIS
• clinical symptoms
• atypical lymphocytosis
• heterophile antibody or specific EBV antibodies.
• Culture of EBV requires 4–6 wk.
• The cultures are observed for 6 wk for signs of cell
transformation:
- proliferation and rapid growth
- mitotic figures: large vacuoles, granular morphology,
and cell aggregation.
Differential Diagnosis
• Cytomegalovirus-adenovirus-viral hepatitis-HIV- rubella.
• Streptococcal pharyngitis: not associated with
hepatosplenomegaly.
- If failure of streptococcal pharyngitis to improve within
48–72 hr you suspect infectious mononucleosis.
• In patients with extremely high or low white blood cell
counts, moderate thrombocytopenia, and even hemolytic
anemia.
You do: bone marrow examination and hematologic
consultation to exclude the possibility of leukemia.
LABORATORY TESTS
• leukocytosis of 10,000–20,000 cells/mm3: In >90% of cases
⅔ are lymphocytes
20–40% atypical lymphocytes
• The atypical lymphocytes are large, with larger eccentric and folded
nuclei with a lower nuclear-to-cytoplasm ratio.
• the highest degree of atypical lymphocytes is classically seen with
EBV infection.
• Mild thrombocytopenia rarely associated with purpura.
• Mild elevation of hepatic transaminases without jaundice.
• Other syndromes with atypical lymphocytosis :
- cytomegalovirus infection
- toxoplasmosis
- viral hepatitis
- rubella
- roseola
- mumps
- tuberculosis
- typhoid
- Mycoplasma
- malaria,
- Some drug reactions.
HETEROPHILE ANTIBODY TEST
• known as Paul-Bunnell antibodies, are IgM
antibodies detected by the Paul-Bunnell-
Davidsohn test for sheep red cell agglutination.
• Titers of >1 : 28 or >1 : 40, depending on the
dilution system used, after absorption with
guinea pig cells are considered positive.
response to viral capsid antigen (VCA) is divided because of
the significant differences noted according to age of the patient.
SPECIFIC EBV ANTIBODIES
TREATMENT
• no specific treatment
• Acyclovir in high doses of acyclovir, with or without corticosteroids:
- decreases viral replication and oropharyngeal shedding
- not reduce the severity or duration of symptoms.
• Rest and symptomatic treatments are the mainstays of management.
• Bed rest is necessary only when the patient has debilitating fatigue.
• Blunt abdominal trauma may predispose to splenic rupture:
advise not to participate in contact sports during the 1st 2–3 wk of
illness.
• Short courses of corticosteroids (<2 wk) may be helpful
for complications. Indications only if complications:
- airway obstruction
- thrombocytopenia with hemorrhaging
- autoimmune hemolytic anemia
- seizures, and meningitis.
• A recommended dosage is prednisone 1 mg/kg/day
(maximum 60 mg/day) or equivalent for 7 days and
tapered over another 7 days.
COMPLICATIONS
• Subcapsular splenic hemorrhage or splenic rupture:
- during the 2nd week of the disease
- rate of <0.5% of cases in adults; much lower in children.
• Rupture is commonly related to trauma, which often may
be mild, and is rarely fatal.
• Airway obstruction:
- due to swelling of tonsils and oropharyngeal lymphoid
tissue
- manifests as drooling, stridor, and difficult breathing.
- give steroids, may need intubation for 24 hours.
COMPLICATIONS-2
Nurological:
• Headache
• seizures and ataxia
• Alice in Wonderland syndrome (metamorphopsia):
Perceptual distortions of sizes, shapes, and spatial
relationships.
• There may be meningitis with nuchal rigidity and
mononuclear cells in the CSF, facial nerve palsy,
transverse myelitis, and encephalitis.
• Guillain-Barré syndrome or Reye syndrome may follow acute
illness.
• Hemolytic anemia, often with a positive Coombs test result and
with cold agglutinins specific for red cell antigen i, occurs in 3% of
cases.
• The onset is typically in the 1st 2 wk of illness and lasts for <1 mo.
• Aplastic anemia is a rare complication that usually presents 3–4 wk
after the onset of illness, usually with recovery in 4–8 days, but
some cases do require bone marrow transplantation.
• Mild thrombocytopenia and neutropenia are common, but severe
thrombocytopenia (<20,000 platelets/μL) or severe neutropenia
(<1,000 neutrophils/μL) are rare.
• Myocarditis or interstitial pneumonia may occur, both resolving in
3–4 wk. Other rare complications include pancreatitis, parotitis,
and orchitis.
COMPLICATIONS-3
PROGNOSIS
• The prognosis for complete recovery is excellent if no
complications ensue during the acute illness.
• The major symptoms typically last 2–4 wk, followed by gradual
recovery.
• Second infections with a different type of EBV (type 1 or type 2)
have been demonstrated in immunocompromised persons.
• Prolonged and debilitating fatigue, malaise, and some disability
that may wax and wane for several weeks to 6 mo are common
complaints even in otherwise unremarkable cases.
• Occasional persistence of fatigue for a few years after
infectious mononucleosis is well recognized.
Epstein barr virus

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Cytomegalovirus
CytomegalovirusCytomegalovirus
Cytomegalovirus
 
Varicella Zoster Virus Infections
Varicella Zoster Virus Infections Varicella Zoster Virus Infections
Varicella Zoster Virus Infections
 
Infectious mononucleosis
Infectious mononucleosisInfectious mononucleosis
Infectious mononucleosis
 
Infectious mononucleosis Made Extremely Simple!!!
Infectious mononucleosis Made Extremely Simple!!! Infectious mononucleosis Made Extremely Simple!!!
Infectious mononucleosis Made Extremely Simple!!!
 
EBV.ppt
EBV.pptEBV.ppt
EBV.ppt
 
Infectious mononucleosis (im) and epstein barr virus
Infectious mononucleosis (im) and epstein barr virusInfectious mononucleosis (im) and epstein barr virus
Infectious mononucleosis (im) and epstein barr virus
 
Herpes virus
Herpes virus Herpes virus
Herpes virus
 
infectious mononucleosis
infectious mononucleosisinfectious mononucleosis
infectious mononucleosis
 
Enteroviruses
EnterovirusesEnteroviruses
Enteroviruses
 
Herpes virus
Herpes virusHerpes virus
Herpes virus
 
Herpes simplex virus
Herpes simplex virusHerpes simplex virus
Herpes simplex virus
 
Infectious Mononucleosis - Pathology
Infectious Mononucleosis - PathologyInfectious Mononucleosis - Pathology
Infectious Mononucleosis - Pathology
 
Cytomegalovirus Made Very Easy!
Cytomegalovirus Made Very Easy!Cytomegalovirus Made Very Easy!
Cytomegalovirus Made Very Easy!
 
Human Herpesviruses INFECTIOUS MONONUCLEOSIS 2016
Human Herpesviruses  INFECTIOUS MONONUCLEOSIS 2016Human Herpesviruses  INFECTIOUS MONONUCLEOSIS 2016
Human Herpesviruses INFECTIOUS MONONUCLEOSIS 2016
 
Rotavirus
RotavirusRotavirus
Rotavirus
 
Viral Haemorrhagic Fevers
Viral Haemorrhagic FeversViral Haemorrhagic Fevers
Viral Haemorrhagic Fevers
 
Hiv infection
Hiv infectionHiv infection
Hiv infection
 
Lab diagnosis of viral infection
Lab diagnosis of viral infectionLab diagnosis of viral infection
Lab diagnosis of viral infection
 
EBV notes
EBV notesEBV notes
EBV notes
 
Opportunistic infections (oi) deepa
Opportunistic infections (oi) deepaOpportunistic infections (oi) deepa
Opportunistic infections (oi) deepa
 

Ähnlich wie Epstein barr virus

14.HIV and periodontium.pptx
14.HIV and periodontium.pptx14.HIV and periodontium.pptx
14.HIV and periodontium.pptxDrNavyadidla
 
Hiv and oppurtunistic infections
Hiv and oppurtunistic infectionsHiv and oppurtunistic infections
Hiv and oppurtunistic infectionsme2432 j
 
Chapter 7 oncogenic viruses
Chapter 7 oncogenic virusesChapter 7 oncogenic viruses
Chapter 7 oncogenic virusesNilesh Kucha
 
epstein-barrvirus-120805023924-phpapp02.pdf
epstein-barrvirus-120805023924-phpapp02.pdfepstein-barrvirus-120805023924-phpapp02.pdf
epstein-barrvirus-120805023924-phpapp02.pdfAimanAlazzabi2
 
Cutaneous manifestations of HIV
Cutaneous manifestations of HIVCutaneous manifestations of HIV
Cutaneous manifestations of HIVYugandhar Tummala
 
chapter 1 viral infection part 2 coursee
chapter 1 viral infection part 2 courseechapter 1 viral infection part 2 coursee
chapter 1 viral infection part 2 courseelunazeid2
 
Lec 3. viral infection
Lec 3. viral infectionLec 3. viral infection
Lec 3. viral infectionAyub Abdi
 
Secondary Immunodeficiency
Secondary ImmunodeficiencySecondary Immunodeficiency
Secondary ImmunodeficiencyUsama Ragab
 
Clinical approach fever +lymphadenopathy
Clinical approach fever +lymphadenopathyClinical approach fever +lymphadenopathy
Clinical approach fever +lymphadenopathyWalaa Manaa
 
CYTOMEGALOVIRUS.pptx for educational purposes
CYTOMEGALOVIRUS.pptx for educational purposesCYTOMEGALOVIRUS.pptx for educational purposes
CYTOMEGALOVIRUS.pptx for educational purposesaryajayakottarathil
 

Ähnlich wie Epstein barr virus (20)

kala Azar
kala Azarkala Azar
kala Azar
 
The human immunodeficiency virus (HIV)
The human immunodeficiency virus (HIV)The human immunodeficiency virus (HIV)
The human immunodeficiency virus (HIV)
 
14.HIV and periodontium.pptx
14.HIV and periodontium.pptx14.HIV and periodontium.pptx
14.HIV and periodontium.pptx
 
Ebstein Barr Virus
Ebstein Barr Virus Ebstein Barr Virus
Ebstein Barr Virus
 
Hiv and oppurtunistic infections
Hiv and oppurtunistic infectionsHiv and oppurtunistic infections
Hiv and oppurtunistic infections
 
HIV and SURGERY(adesiyakan)
HIV and SURGERY(adesiyakan)HIV and SURGERY(adesiyakan)
HIV and SURGERY(adesiyakan)
 
Chapter 7 oncogenic viruses
Chapter 7 oncogenic virusesChapter 7 oncogenic viruses
Chapter 7 oncogenic viruses
 
epstein-barrvirus-120805023924-phpapp02.pdf
epstein-barrvirus-120805023924-phpapp02.pdfepstein-barrvirus-120805023924-phpapp02.pdf
epstein-barrvirus-120805023924-phpapp02.pdf
 
Cutaneous manifestations of HIV
Cutaneous manifestations of HIVCutaneous manifestations of HIV
Cutaneous manifestations of HIV
 
IMN.pptx
IMN.pptxIMN.pptx
IMN.pptx
 
Human Herpes's zoster (infectious mononuclosis)
Human Herpes's zoster (infectious mononuclosis)Human Herpes's zoster (infectious mononuclosis)
Human Herpes's zoster (infectious mononuclosis)
 
Aids and periodontium
Aids and periodontiumAids and periodontium
Aids and periodontium
 
Oncogenic viruses
Oncogenic virusesOncogenic viruses
Oncogenic viruses
 
Hiv
HivHiv
Hiv
 
chapter 1 viral infection part 2 coursee
chapter 1 viral infection part 2 courseechapter 1 viral infection part 2 coursee
chapter 1 viral infection part 2 coursee
 
Lec 3. viral infection
Lec 3. viral infectionLec 3. viral infection
Lec 3. viral infection
 
Secondary Immunodeficiency
Secondary ImmunodeficiencySecondary Immunodeficiency
Secondary Immunodeficiency
 
Acute multiple Oral ulcers
Acute multiple Oral ulcersAcute multiple Oral ulcers
Acute multiple Oral ulcers
 
Clinical approach fever +lymphadenopathy
Clinical approach fever +lymphadenopathyClinical approach fever +lymphadenopathy
Clinical approach fever +lymphadenopathy
 
CYTOMEGALOVIRUS.pptx for educational purposes
CYTOMEGALOVIRUS.pptx for educational purposesCYTOMEGALOVIRUS.pptx for educational purposes
CYTOMEGALOVIRUS.pptx for educational purposes
 

Mehr von mohammed Qazzaz (20)

Nocturnal Enuresis
Nocturnal EnuresisNocturnal Enuresis
Nocturnal Enuresis
 
‫أَيَّاً يَكُن
‫أَيَّاً يَكُن ‫أَيَّاً يَكُن
‫أَيَّاً يَكُن
 
DVT.. Deep vein thrombosis.
DVT.. Deep vein thrombosis.DVT.. Deep vein thrombosis.
DVT.. Deep vein thrombosis.
 
Croup
CroupCroup
Croup
 
Blood film
Blood filmBlood film
Blood film
 
Iron deficiency in children
Iron deficiency in childrenIron deficiency in children
Iron deficiency in children
 
Poliomyelitis
PoliomyelitisPoliomyelitis
Poliomyelitis
 
Migraine
MigraineMigraine
Migraine
 
Breastfeeding
Breastfeeding Breastfeeding
Breastfeeding
 
Rickettsial diseases
Rickettsial diseasesRickettsial diseases
Rickettsial diseases
 
Herbal medicine
Herbal medicineHerbal medicine
Herbal medicine
 
Conjuctival diseases
Conjuctival diseasesConjuctival diseases
Conjuctival diseases
 
الاجهاض
الاجهاضالاجهاض
الاجهاض
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
lacrimal system anatomy and clinical
lacrimal system anatomy and clinicallacrimal system anatomy and clinical
lacrimal system anatomy and clinical
 
Enegry drink hazards
Enegry drink hazardsEnegry drink hazards
Enegry drink hazards
 
Autism
AutismAutism
Autism
 
Vomiting
VomitingVomiting
Vomiting
 
Mid cycle pain
Mid cycle painMid cycle pain
Mid cycle pain
 
Obesity
ObesityObesity
Obesity
 

Kürzlich hochgeladen

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 

Kürzlich hochgeladen (20)

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 

Epstein barr virus

  • 2. Infectious mononucleosis • Caused by Epstein-Barr virus (EBV). • Characterized by: fatigue, malaise, fever, sore throat, and generalized lymphadenopathy. • Was called glandular fever: Because it has mononuclear lymphocytosis with atypical- lymphocytes. Other infections may cause infectious mononucleosis-like illnesses
  • 3. ETIOLOGY • EBV, a member of the γ-herpesviruses, causes >90% of cases of infectious mononucleosis. • Two distinct types of EBV: - type 1 (type A): more prevalent worldwide - type 2 (type B): more common in Africa • Both types lead to persistent, lifelong, latent infection. • Dual infections with both types have been documented among immunocompromised persons.
  • 4. Infectious mononucleosis-like illnesses 5–10% of are caused by: - CMV -Toxoplasma gondii - adenovirus - viral hepatitis - HIV - rubella virus. • Causes of majority of mononucleosis-like illnesses still unknown.
  • 5. EPIDEMIOLOGY • EBV infects >95% of the world's population. • Transmitted by: 1. sexual intercourse 2. through oral secretions. 3. In children by exchange of saliva • Not transmitted by: - Nonintimate contact - fomites.
  • 6. • EBV is shed in oral secretions consistently for >6 mo after acute infection and then intermittently for life. • 20–30% excrete virus at any particular time. • 60–90% in infected immunosuppressed patients. • Immunosuppression help reactivation of latent EBV • Also found in male and female genital secretions.
  • 7. • Infection with EBV occurs during infancy and early childhood. • 1ry infection in children usually inapparent. • in >50% adolescents and adults: classic triad: - fatigue - pharyngitis - generalized lymphadenopathy.
  • 8. INCIDENCE: • Estimated: up to 70/100,000 persons/yr. • in young adults:1/1,000 persons/yr. • Almost all adults in USA are seropositive.
  • 9. PATHOGENESIS • Infection of the oral epithelial cells cause pharyngitis • viral replication and cell lysis. • spreads to near structures as the salivary glands • viremia and infection of B lymphocytes and the lymphoreticular system, including the liver and spleen.
  • 10. • Characteristic atypical lymphocytes are CD8+ T lymphocytes. • Transient reversal of the normal 2 : 1 CD4+/CD8+(helper:suppressorT-lymphocytes) • This causes cytokine release which causes many of the clinical manifestations.
  • 11. • Sexual transmission infects the epithelial cells of the uterine cervix. • EBV is consistently found intracellularly in smooth muscle cells of leiomyosarcomas of immunocompromised persons. • EBV has lifelong latent infection after the primary illness. • The latent virus found in oropharyngeal epithelial cells and in memory B lymphocytes.
  • 12. ONCOGENESIS • EBV was the 1st human virus to be associated with malignancy. • Spectrum of EBV infection: - self-limited infectious mononucleosi - nonmalignant proliferations - malignancies in lymphoid and epithelial cell.
  • 13. ONCOGENESIS-2 • Benign EBV-associated proliferations include: - Oral hairy leukoplakia, primarily in adults with AIDS - Lymphoid interstitial pneumonitis, in children with AIDS. • Malignant EBV-associated proliferations include: - nasopharyngeal carcinoma - Burkitt lymphoma - Hodgkin disease - lymphoproliferative disorders, and - leiomyosarcoma in immunodeficient including AIDS.
  • 14. Nasopharyngeal carcinoma • It is worldwide • 10 times more common in southern China, where it is the most common malignant tumor among adult men. • Patients present with: - cervical lymphadenopathy - eustachian tube blockage - nasal obstruction with epistaxis.
  • 15. Nasopharyngeal carcinoma-cont • Patients have elevated EBV antibody titers that are both diagnostic and prognostic.
  • 16. Nasopharyngeal carcinoma-cont • Diagnosis: - CT and MRI - Biopsy from lymph nodes or masses - Surgery is important for staging and diagnosis. Treatment: • Radiation therapy is effective for control of the primary tumor and regional nodal metastases. • Chemotherapy is effective but not always curative. Prognosis: good if the tumor is localized.
  • 17. Endemic (African) Burkitt lymphoma • Often in the jaw • The most common childhood cancer in equatorial East Africa • The median age at onset is 5 yr. • These regions are endemic for Plasmodium falciparum malaria and have a high rate of EBV infection early in life. • Malarial exposure acts as a B-lymphocyte mitogen increasing the risk of Burkitt lymphoma. • Approximately 98% of cases of endemic Burkitt lymphoma contain the EBV genome.
  • 18. 1Other Malignancies- • Infection with EBV also increase the risk for Hodgkin disease. • EBV is find in the Reed-Sternberg cells which are pathognomonic malignant cells of Hodgkin disease. • Duncan syndrome: (X-linked lymphoproliferative syndrome): is associated with severe, persistent, and fatal EBV infection . • Many Immunodeficiency syndromes are associated with an increased incidence of EBV-associated B-lymphocyte lymphoma include: - X-linked lymphoproliferative syndrome, - common-variable immunodeficiency, - ataxia-telangiectasia, - Wiskott-Aldrich syndrome, and - Chédiak-Higashi syndrome.
  • 19. - T-lymphocyte lymphomas (including lethal midline) - angio-immunoblastic lymphadenopathy-like lymphoma - thymomas and thymic carcinomas - supraglottic laryngeal carcinomas - lympho-epithelial tumors of the respiratory tract and GIT. - gastric adenocarcinoma. 2Other Malignancies-
  • 20. CLINICAL MANIFESTATIONS of EBV infection • The incubation period: 30–50 days. • 1ry infection in infants and young children is silent. • In older patients: insidious and vague onset.
  • 21. Prodromal symptoms: last 1–2 wk. • Malaise • fatigue • Fever & headache • sore throat, nausea, abdominal pain • myalgia. • Splenic enlargement :may cause left upper abdominal discomfort and tenderness
  • 22. Physical examination • generalized lymphadenopathy (90% of cases), • splenomegaly (50% of cases), • hepatomegaly (10% of cases). • Lymphadenopathy : Common in: - anterior and posterior cervical - submandibular less common in: axillary and inguinal. Epitrochlear lymphadenopathy is suggestive of infectious mononucleosis.
  • 23. • elevated liver enzymes are common. • Splenomegaly to 2–3 cm below the costal margin is typical; massive enlargement is uncommon. • The sore throat is often accompanied by moderate to severe pharyngitis with marked tonsillar enlargement, occasionally with exudates . • Petechiae at junction of the hard and soft palate • Others: rashes and edma of the eyelids .
  • 24.
  • 25. • Maculopapular in 3–15% of patients • Up to 80% of patients have “ampicillin rash” if treated with ampicillin or amoxicillin. • This vasculitic rash is immune mediated and resolves without specific treatment. • Gianotti-Crosti syndrome: a symmetrical rash on the cheeks with multiple erythematous papules, which may coalesce into plaques, and persists for 15–50 days.
  • 26. DIAGNOSIS • clinical symptoms • atypical lymphocytosis • heterophile antibody or specific EBV antibodies. • Culture of EBV requires 4–6 wk. • The cultures are observed for 6 wk for signs of cell transformation: - proliferation and rapid growth - mitotic figures: large vacuoles, granular morphology, and cell aggregation.
  • 27. Differential Diagnosis • Cytomegalovirus-adenovirus-viral hepatitis-HIV- rubella. • Streptococcal pharyngitis: not associated with hepatosplenomegaly. - If failure of streptococcal pharyngitis to improve within 48–72 hr you suspect infectious mononucleosis. • In patients with extremely high or low white blood cell counts, moderate thrombocytopenia, and even hemolytic anemia. You do: bone marrow examination and hematologic consultation to exclude the possibility of leukemia.
  • 28. LABORATORY TESTS • leukocytosis of 10,000–20,000 cells/mm3: In >90% of cases ⅔ are lymphocytes 20–40% atypical lymphocytes • The atypical lymphocytes are large, with larger eccentric and folded nuclei with a lower nuclear-to-cytoplasm ratio. • the highest degree of atypical lymphocytes is classically seen with EBV infection. • Mild thrombocytopenia rarely associated with purpura. • Mild elevation of hepatic transaminases without jaundice.
  • 29. • Other syndromes with atypical lymphocytosis : - cytomegalovirus infection - toxoplasmosis - viral hepatitis - rubella - roseola - mumps - tuberculosis - typhoid - Mycoplasma - malaria, - Some drug reactions.
  • 30. HETEROPHILE ANTIBODY TEST • known as Paul-Bunnell antibodies, are IgM antibodies detected by the Paul-Bunnell- Davidsohn test for sheep red cell agglutination. • Titers of >1 : 28 or >1 : 40, depending on the dilution system used, after absorption with guinea pig cells are considered positive.
  • 31. response to viral capsid antigen (VCA) is divided because of the significant differences noted according to age of the patient. SPECIFIC EBV ANTIBODIES
  • 32. TREATMENT • no specific treatment • Acyclovir in high doses of acyclovir, with or without corticosteroids: - decreases viral replication and oropharyngeal shedding - not reduce the severity or duration of symptoms. • Rest and symptomatic treatments are the mainstays of management. • Bed rest is necessary only when the patient has debilitating fatigue. • Blunt abdominal trauma may predispose to splenic rupture: advise not to participate in contact sports during the 1st 2–3 wk of illness.
  • 33. • Short courses of corticosteroids (<2 wk) may be helpful for complications. Indications only if complications: - airway obstruction - thrombocytopenia with hemorrhaging - autoimmune hemolytic anemia - seizures, and meningitis. • A recommended dosage is prednisone 1 mg/kg/day (maximum 60 mg/day) or equivalent for 7 days and tapered over another 7 days.
  • 34. COMPLICATIONS • Subcapsular splenic hemorrhage or splenic rupture: - during the 2nd week of the disease - rate of <0.5% of cases in adults; much lower in children. • Rupture is commonly related to trauma, which often may be mild, and is rarely fatal. • Airway obstruction: - due to swelling of tonsils and oropharyngeal lymphoid tissue - manifests as drooling, stridor, and difficult breathing. - give steroids, may need intubation for 24 hours.
  • 35. COMPLICATIONS-2 Nurological: • Headache • seizures and ataxia • Alice in Wonderland syndrome (metamorphopsia): Perceptual distortions of sizes, shapes, and spatial relationships. • There may be meningitis with nuchal rigidity and mononuclear cells in the CSF, facial nerve palsy, transverse myelitis, and encephalitis.
  • 36. • Guillain-Barré syndrome or Reye syndrome may follow acute illness. • Hemolytic anemia, often with a positive Coombs test result and with cold agglutinins specific for red cell antigen i, occurs in 3% of cases. • The onset is typically in the 1st 2 wk of illness and lasts for <1 mo. • Aplastic anemia is a rare complication that usually presents 3–4 wk after the onset of illness, usually with recovery in 4–8 days, but some cases do require bone marrow transplantation. • Mild thrombocytopenia and neutropenia are common, but severe thrombocytopenia (<20,000 platelets/μL) or severe neutropenia (<1,000 neutrophils/μL) are rare. • Myocarditis or interstitial pneumonia may occur, both resolving in 3–4 wk. Other rare complications include pancreatitis, parotitis, and orchitis. COMPLICATIONS-3
  • 37. PROGNOSIS • The prognosis for complete recovery is excellent if no complications ensue during the acute illness. • The major symptoms typically last 2–4 wk, followed by gradual recovery. • Second infections with a different type of EBV (type 1 or type 2) have been demonstrated in immunocompromised persons. • Prolonged and debilitating fatigue, malaise, and some disability that may wax and wane for several weeks to 6 mo are common complaints even in otherwise unremarkable cases. • Occasional persistence of fatigue for a few years after infectious mononucleosis is well recognized.